share_log

Watching CytoSorbents; Hearing Zacks Small-Cap Research Sets $6 Price Target; Says CytoSorbents Reports 2nd Quarter 2023 Financial And Operating Results Which Showed Strong Product Revenue Growth And An Improved Cost Structure

Watching CytoSorbents; Hearing Zacks Small-Cap Research Sets $6 Price Target; Says CytoSorbents Reports 2nd Quarter 2023 Financial And Operating Results Which Showed Strong Product Revenue Growth And An Improved Cost Structure

观看 CytoSorbents;Hearing Zacks Small-Cap Research 设定了 6 美元的目标股价;CytoSorbents 公布了 2023 年第二季度的财务和经营业绩,显示产品收入强劲增长,成本结构有所改善
Benzinga ·  2023/08/03 13:14

Watching CytoSorbents; Hearing Zacks Small-Cap Research Sets $6 Price Target; Says CytoSorbents Reports 2nd Quarter 2023 Financial And Operating Results Which Showed Strong Product Revenue Growth And An Improved Cost Structure

观看 CytoSorbents;Hearing Zacks Small-Cap Research 设定了 6 美元的目标股价;CytoSorbents 公布了 2023 年第二季度的财务和经营业绩,显示产品收入强劲增长,成本结构有所改善

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发